Lung Ultrasound-guided Hemodynamic Optimization

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire, Amiens

About this trial

The formalized expert recommendation of the French Society of Anesthesia and Intensive Care recommends guiding vascular filling by measuring the stroke volume (SV) in surgical patients considered at high risk. Vascular filling should be continued in the event of preload dependence and stopped in the event of the appearance of preload independence. The aim is to avoid vascular overload due to excessive vascular filling. The application of this recommendation has resulted in a reduction in postoperative morbidity, length of hospital stay and time to return to oral feeding. The superiority of this strategy is now being questioned and the predictive indices of response to vascular filling (static and dynamic) have many limitations. In addition, none of the cardiac output monitors are the gold standard for intraoperative use.

Through the study of artefacts, lung ultrasound has been gaining ground over the last twenty years, particularly in cardiology, nephrology and intensive care. By analogy with radiological B-lines, ultrasound B-lines result from the reverberation of ultrasound on the subpleural inter-lobular septa thickened by oedema. The Fluid Administration Limited by Lung Sonography (FALLS) protocol, described by Lichtenstein et al, is defined as the visualisation of new B lines during a vascular filling test. If a B-line appears in an area where it was not present during vascular filling, the most likely diagnosis is hydrostatic overload of the subpleural interstitial septum. This appearance of B-lines occurs at a sub-clinical stage.

The use of lung ultrasound could allow real-time assessment of vascular filling and its tolerance during the intraoperative period. The main objective of the study is to demonstrate a decrease in the incidence of postoperative complications (organ failure) (as defined by international guidelines) when using lung ultrasound-guided haemodynamic optimisation compared to standard optimisation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age> 18 years old

Abdominal, orthopaedic or vascular surgery with general anaesthesia

Patient of legal age ≥ 18 years.

ASA score ≥ II

Disqualifiers

Severe untreated or unbalanced hypertension on treatment.

Preoperative renal failure on dialysis.

Acute heart failure.

Acute coronary insufficiency.

Trial design

Design model

Parallel

Treatments tested in this trial

  • noradrenaline and vascular filling

    Drug

    In the control group, the haemodynamic management of the patients is done according to usual practice by maintaining blood pressure with noradrenaline and optimising stroke volume with vascular filling.

  • pulmonary ultrasound after vascular filling

    Procedure/Surgery

    In the interventional group, intraoperative haemodynamic management is based on an algorithm that includes measurement of the number of B-lines appearing on pulmonary ultrasound after vascular filling. Monitoring of the stroke volume will also be performed in this group in order to stop the vascular filling if the ESV does not increase by more than 10%.

Treatment groups

350 Participants
are divided into 2 treatment groups
Group A: Control groupActive comparator 1 intervention
Group B: pulmonary ultrasound groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Number of Postoperative Organ failure

Organ failure is defined according to the recommendations of the European Society of Anaesthesia (ESA)

Time frame
within 7 days

Secondary outcomes

1

length of hospital stay

Number of days staying in hospital

Time frame
7 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.